Nikkei ends at 30-yr high as drug makers rally on COVID-19 treatment news

Japan’s benchmark Nikkei share average inched up to close at a fresh three-decade high on Tuesday, as drug makers led the charge on a report that Chugai Pharmaceutical’s drug was effective in treating …
( read original story …)